What kind of randomised trials do patients and clinicians need?

Evidence-Based Medicine

Volumn 14, Issue 4, 2009, Pages 101-103

  Zwarenstein, Merrick ^a   Treweek, Shaun ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL RESEARCH; CONTROL GROUP; GENERAL PRACTITIONER; MEDICAL PRACTICE; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PHYSICIAN ATTITUDE; SHORT SURVEY;

RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 68149164444     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebm.14.4.101     Document Type: Short Survey

References (11)

1. Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967;20:637-648
2. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 2005;365:82-93.
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991;325:445-453
4. Wing LM, Reid CM, Ryan P, et al, for the Second Australian National Blood Pressure Study Group. A comparison of outcomes with angiotensin-converting- enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-592
5. Vallvé C. [A critical review of the pragmatic clinical trial]. Med Clin (Barc) 2003;121:384-388
6. Van Spall HG, Toren A, Kiss A, et al. Eligibility criteria of randomised controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007;297:1233-1240
7. US Food and Drug Administration. www.fda.gov/oc/ohrt/irbs/drugsbiologics. html#study (accessed 14 Mar 09).
8. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:1624-1632
9. Congressional Budget Office. Research on the comparative effectiveness of medical treatments: issues and options for an expanded federal role. Report pub no. 2975. Washington: Congressional Budget Office, Dec 2007. www.cbo.gov/ftpdocs/88xx/doc8891/12-18-ComparativeEffectiveness.pdf (accessed 14 Mar 09).
10. Thorpe KE, Zwarenstein M, Oxman AD, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009;62:464-7511.
11. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.